The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Changes in Forced Expiratory Volume in 1 Second over Time in COPD
Open accessAbstract
BACKGROUND: A key feature of chronic obstructive pulmonary disease (COPD) is an accelerated rate of decline in forced expiratory volume in 1 second (FEV(1)), but data on the variability and determinants of this change in patients who have established disease are scarce. METHODS: We analyzed the changes in FEV(1) after administration of a bronchodilator over a 3-year period in 2163 patients. A random-coefficient model was used to evaluate possible predictors of both FEV(1) levels and their changes over time. RESULTS: The mean (±SE) rate of change in FEV(1) was a decline of 33±2 ml per year, with significant variation among the patients studied. The between-patient standard deviation for the rate of decline was 59 ml per year. Over the 3-year study period, 38% of patients had an estimated decline in FEV(1) of more than 40 ml per year, 31% had a decline of 21 to 40 ml per year, 23% had a change in FEV(1) that ranged from a decrease of 20 ml per year to an increase of 20 ml per year, and 8% had an increase of more than 20 ml per year. The mean rate of decline in FEV(1) was 21±4 ml per year greater in current smokers than in current nonsmokers, 13±4 ml per year greater in patients with emphysema than in those without emphysema, and 17±4 ml per year greater in patients with bronchodilator reversibility than in those without reversibility. CONCLUSIONS: The rate of change in FEV(1) among patients with COPD is highly variable, with increased rates of decline among current smokers, patients with bronchodilator reversibility, and patients with emphysema.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global Initiative for Chronic Obstructive Lung Disease
Gerald, L. B., & Bailey, W. C. (2002) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200207000-00004 · Cited by 5,830
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,248
Self-citationSusceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
Hurst, J. R., Vestbo, J., Anzueto, A., Locantore, N., Müllerova, H., Tal-Singer, R., Miller, B., Lomas, D. A., Agusti, A., MacNee, W., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909883 · Cited by 2,981
Self-citationThe natural history of chronic airflow obstruction.
Fletcher, C., & Peto, R. (1977) · BMJ · doi:10.1136/bmj.1.6077.1645 · Cited by 2,370
Donaldson, G. C. (2002) · Thorax · doi:10.1136/thorax.57.10.847 · Cited by 2,272
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
Tashkin, D. P., Celli, B., Senn, S., Burkhart, D., Kesten, S., Menjoge, S., & Decramer, M. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805800 · Cited by 1,604
Self-citationCharacterisation of COPD heterogeneity in the ECLIPSE cohort
the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators, Agusti, A., Calverley, P. M., Celli, B., Coxson, H. O., Edwards, L. D., Lomas, D. A., MacNee, W., Miller, B. E., Rennard, S., et al. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-122 · Cited by 1,157
Self-citationEvaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)
Vestbo, J., Anderson, W., Coxson, H. O., Crim, C., Dawber, F., Edwards, L., Hagan, G., Knobil, K., Lomas, D. A., MacNee, W., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00111707 · Cited by 759
Self-citationCelli, B. R., Thomas, N. E., Anderson, J. A., Ferguson, G. T., Jenkins, C. R., Jones, P. W., Vestbo, J., Knobil, K., Yates, J. C., & Calverley, P. M. A. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200712-1869oc · Cited by 748
Self-citationThe natural history of chronic bronchitis and emphysema
Little, G. M. (1979) · Resuscitation · doi:10.1016/0300-9572(79)90018-2 · Cited by 600
KANNER, R. E., ANTHONISEN, N. R., & CONNETT, J. E. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.3.2010017 · Cited by 583
Raherison, C., & Girodet, P.-O. (2009) · European Respiratory Review · doi:10.1183/09059180.00003609 · Cited by 514
Bronchodilator reversibility testing in chronic obstructive pulmonary disease
Calverley, P. M. A. (2003) · Thorax · doi:10.1136/thorax.58.8.659 · Cited by 512
Self-citationDecramer, M., Celli, B., Kesten, S., Lystig, T., Mehra, S., & Tashkin, D. P. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61298-8 · Cited by 495
Self-citationDefinition, epidemiology and natural history of COPD
Viegi, G., Pistelli, F., Sherrill, D. L., Maio, S., Baldacci, S., & Carrozzi, L. (2007) · European Respiratory Journal · doi:10.1183/09031936.00082507 · Cited by 430
Epidemiology of chronic obstructive pulmonary disease
Antó, J. M., Vermeire, P., Vestbo, J., & Sunyer, J. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.17509820 · Cited by 427
Self-citationThe natural history of chronic bronchitis and emphysema
Wright, P. (1977) · British Journal of Diseases of the Chest · doi:10.1016/0007-0971(77)90115-2 · Cited by 348
Jenkins, C. R., Jones, P. W., Calverley, P. M., Celli, B., Anderson, J. A., Ferguson, G. T., Yates, J. C., Willits, L. R., & Vestbo, J. (2009) · Respiratory Research · doi:10.1186/1465-9921-10-59 · Cited by 345
Self-citationBrutsche, M. H. (2006) · Thorax · doi:10.1136/thx.2005.052241 · Cited by 187
Bridevaux, P.-O., Gerbase, M. W., Probst-Hensch, N. M., Schindler, C., Gaspoz, J.-M., & Rochat, T. (2008) · Thorax · doi:10.1136/thx.2007.093724 · Cited by 167
Quantifying the Extent of Emphysema:
Gietema, H. A., Müller, N. L., Fauerbach, P. V. N., Sharma, S., Edwards, L. D., Camp, P. G., & Coxson, H. O. (2011) · Academic Radiology · doi:10.1016/j.acra.2011.01.011 · Cited by 132
Self-citationBiomarkers in Chronic Obstructive Pulmonary Disease
Sin, D. D., & Vestbo, J. (2009) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200904-019ds · Cited by 72
Self-citation
Cited by
Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease
Lange, P., Celli, B., Agustí, A., Boje Jensen, G., Divo, M., Faner, R., Guerra, S., Marott, J. L., Martinez, F. D., Martinez-Camblor, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411532 · Cited by 1,284
Self-citationIndacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD
Wedzicha, J. A., Banerji, D., Chapman, K. R., Vestbo, J., Roche, N., Ayers, R. T., Thach, C., Fogel, R., Patalano, F., & Vogelmeier, C. F. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1516385 · Cited by 844
Self-citationChronic obstructive pulmonary disease
Barnes, P. J., Burney, P. G. J., Silverman, E. K., Celli, B. R., Vestbo, J., Wedzicha, J. A., & Wouters, E. F. M. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.76 · Cited by 734
Self-citationUpdate on the Pathogenesis of Chronic Obstructive Pulmonary Disease
Agustí, A., & Hogg, J. C. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1900475 · Cited by 551
Lim, J. U., Lee, J. H., Kim, J. S., Hwang, Y. I., Kim, T.-H., Lim, S. Y., Yoo, K. H., Jung, K.-S., Kim, Y. K., & Rhee, C. K. (2017) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s141295 · Cited by 549
Metadata
- Authors
- Vestbo, J., Edwards, L. D., Scanlon, P. D., Yates, J. C., Agusti, A., Bakke, P., Calverley, P. M. A., Celli, B., Coxson, H. O., Crim, C., Lomas, D. A., MacNee, W., Miller, B. E., Silverman, E. K., Tal-Singer, R., Wouters, E., & Rennard, S. I.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-09-29
- Volume
- 365
- Issue
- 13
- Pages
- 1184-1192
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2171676943
- Cited by
- 963
- References
- 22
- FWCI
- 61.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.